Invex mentioned in article below (thanks @spnc on the TLX forum).
https://bit.ly/3EVSYax
Phase III Trials: These ASX health stocks are on the pivotal home stretch
20 October 2022
Neuren (ASX: NEU) share price up ~285% in past year as it awaits FDA drug approval
Companies in Phase III (pivotal) or about to start
Dimerix (ASX: DMX)
Telix Pharmaceuticals (ASX: TLX)
Invex Therapeutics (ASX: IXC)
Paradigm Biopharmaceuticals (ASX: PAR)
Medlab Clinical (ASX: MDC)
Invex mentioned in article below (thanks @spnc on the TLX...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.260M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 68013 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 8695 | 1 |
View Market Depth
| Last trade - 16.12pm 16/08/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable